|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Strong Sell||Sell||Strong Sell|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Strong Sell|
|Summary||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Belt Hold Bearish||15||Current|
|Belt Hold Bearish||1H||Current|
|Belt Hold Bullish||1W||Current|
|Morning Doji Star||1W||1||Sep 08, 2019|
|Dragonfly Doji||1D||1||Sep 19, 2019|
|Bullish doji Star||1W||2||Sep 01, 2019|
GlaxoSmithKline Consumer Nigeria Plc is a Nigeria-based research-based pharmaceutical and healthcare company. The principal activities of the Company are manufacturing, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's operating segments include Pharmaceuticals and Consumer Healthcare. The Consumer Healthcare segment includes oral care, over-the-counter (OTC) medicines and nutritional healthcare. The Pharmaceuticals segment consists of antibacteria, vaccines and prescription drugs. The Company offers Consumer Healthcare brands, such as Panadol, Andrews Liver Salt, Macleans, Otrivin, Sensodyne, Voltaren and a range of pharmaceuticals, including Ampiclox, Amoxil, Augmentin, Zentel, Halfan and vaccines. Global Manufacturing and Supply (GMS) is the manufacturing unit of the Company located in Agbara, Ogun State.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.